Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Vaccines|July 29, 2023
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical StudyIhsan Ates, Ayse Batirel, Mehtap Aydin, et al.
Experimental Hematology & Oncology|June 9, 2026
Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancerTaha Koray Sahin, Cemal Orhan, Ibrahim Hanifi Ozercan, et al.
Current Medical Research and Opinion|May 29, 2024
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry studyNuri Karadurmus, Muhammet Ali Kaplan, Mehmet Ali Nahit Sendur, et al.
Cancers|February 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)Sercan On, Selin Cebeci, Zeynep Hande Turna, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 25, 2024
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)Arif Akyildiz, Deniz Can Guven, Baris Koksal, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from TurkeyMuhammet Bekir Hacioglu, Osman Kostek, Senem Karabulut, et al.
Medicine|November 14, 2023
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from TurkeyArif Akyildiz, Deniz Can Guven, Ahmet Anil Ozluk, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|April 17, 2025
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)Nargiz Majidova, Sendag Yaslıkaya, Maral Martin Mıldanoglu, et al.
Journal of Clinical Medicine|January 28, 2026
Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung CancerAyse Nuransoy Cengiz, Oktay Bozkurt, Muhammet Cengiz, et al.
Expert Review of Anticancer Therapy|January 9, 2026
Impact of renin-angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non-small cell lung cancerEmel Mutlu Ozkan, Ibrahim Karadağ, Elif Sahın, et al.
Pageof 16